Pharmaceuticals - Tanzania

Tanzania

The revenue generated in the Pharmaceuticals market in Tanzania is projected to reach US$243.50m in 2024.
Among the various markets, the largest market in Tanzania is Oncology Drugs, which is expected to have a market volume of US$36.91m in 2024.
The revenue in the Pharmaceuticals market is expected to show an annual growth rate of 5.88% from 2024 to 2029, resulting in a market volume of US$324.00m by 2029.
In comparison to other countries globally, United States is expected to generate the highest revenue in the Pharmaceuticals market, reaching US$630.30bn in 2024.
Tanzania is investing in the expansion of its pharmaceutical industry to improve access to healthcare for its growing population.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Tanzania has been experiencing a steady growth in recent years.

Customer preferences: The customer preferences in Tanzania's pharmaceutical market are driven by the country's high disease burden. Tanzania has a high prevalence of infectious diseases such as malaria, HIV/AIDS, and tuberculosis. As a result, there is a high demand for pharmaceutical products that can treat these diseases. Additionally, there is a growing demand for chronic disease medications such as diabetes and hypertension treatments.

Trends in the market: One of the major trends in Tanzania's pharmaceutical market is the growth of the generic drug segment. This growth is driven by the government's efforts to increase access to affordable healthcare for its citizens. The government has implemented policies that encourage the use of generic drugs in public health facilities. This has led to an increase in the production and consumption of generic drugs in the country.Another trend in the market is the increasing use of technology in healthcare delivery. There is a growing number of mobile health applications and telemedicine services in the country. These technologies are being used to improve access to healthcare services, especially in rural areas.

Local special circumstances: Tanzania's pharmaceutical market is characterized by a high level of fragmentation. There are many small and medium-sized enterprises that operate in the market. This has led to intense competition among players in the market. Additionally, the market is heavily regulated, which makes it difficult for new players to enter.

Underlying macroeconomic factors: Tanzania's pharmaceutical market is influenced by several macroeconomic factors. One of the key factors is the country's population growth. Tanzania has one of the fastest-growing populations in the world, which is driving demand for healthcare services. Additionally, the government's efforts to improve access to healthcare services are also driving growth in the market. The government has invested heavily in healthcare infrastructure, including the construction of new hospitals and health centers. Finally, Tanzania's economy has been growing steadily in recent years, which is increasing the purchasing power of consumers. This is leading to an increase in demand for pharmaceutical products.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.